How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice

Arch Ital Urol Androl. 2022 Sep 26;94(3):369-370. doi: 10.4081/aiua.2022.3.369.

Abstract

To the Editor, The exact time to stop bladder cancer patient's follow-up is not well known and there is not a clear recommendation on if and when stop to follow a patient managed for muscle invasive bladder cancer (MIBC). Major urological guidelines do not provide a precise indication on the timing of follow-up, and there is currently no real consensus on optimal time schedule [...].

MeSH terms

  • Humans
  • Muscles
  • Neoplasm Invasiveness
  • Urinary Bladder Neoplasms* / therapy